Medical device company developing and marketing minimally invasive surgical access tools for improved control, access and visibility.


CONMED Announces Definitive Agreement to Acquire SurgiQuest, Inc.

CONMED Corporation (NASDAQ: CNMD) announced a definitive agreement to acquire privately-held SurgiQuest, Inc. for $265 million on a cash-free, debt-free basis.

Surgiquest Names Jaime Landman, M.D. Chief Medical Officer

SurgiQuest, Inc., a leading provider of innovative access technologies for minimally invasive surgery (MIS), today announced the appointment of Jaime Landman, M.D. as Chief Medical Director of the Company.

SurgiQuest’s AirSealĀ® iFS System Tested for TAMIS Procedure

The Training Center of AIS Channel is a new educational system for surgeons in formation, composed by a variety of courses dedicated to diverse pathologies and minimally invasive techniques for colon diseases.

Two River Cities Portfolio Companies to Present at J.P. Morgan Healthcare Conference

Surgiquest and EndoChoice to present at J.P. Morgan Healthcare Conference.

River Cities Invests $5M In Medical Firm

Downtown-based River Cities Capital Funds just completed its biggest investment of the year, and it’s looking for more.





River Cities Fund IV

Year Invested


City and State

Milford, CT


Portfolio Manager

Carter McNabb